Shuang Li, MD, PhD

Psychiatric Neurotherapeutics Program, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts

  • 1Article
  • 5.1KReads1
  • 2025Active
  • 8Collaborators
  • 6Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Shuang Li, MD, PhD, is affiliated with the Psychiatric Neurotherapeutics Program at McLean Hospital and the Department of Psychiatry at Harvard Medical School. Li has published on treatment-resistant depression, focusing on comparative effects of repeated ketamine infusion versus intranasal esketamine. Contributions include a retrospective chart review examining these interventions. Frequent collaborators include Amanda Sedgewick, Brian Boyle, Courtney Miller, Danika Dai, and Paula Bolton.

Publications

JCP
Comparative Effects of Repeated Ketamine Infusion vs Intranasal Esketamine in Patients with Treatment Resistant Depression: A Retrospective Chart Review

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.